Evidence map›Paper›PMID 33397934›Full record

ArticleNature communications2021

The order and logic of CD4 versus CD8 lineage choice and differentiation in mouse thymus.

Mohammad M Karimi, Ya Guo, Xiaokai Cui, Husayn A Pallikonda, Veronika Horková, Yi-Fang Wang, Sara Ruiz Gil, Gustavo Rodriguez-Esteban, Irene Robles-Rebollo, Ludovica Bruno and 11 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Generation of effector CD4Stem cell reports · 2026
    Article
  3. Review
  4. Article
  5. Rag1-based time-stamp tracing of T-cell developmental origins.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Immune aberrations in thymic epithelial tumors.Mediastinum (Hong Kong, China) · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 5 countries.

Mohammad M KarimiMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.ORCID 0000-0001-5017-1252
Ya GuoMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Xiaokai CuiMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Husayn A PallikondaMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.ORCID 0000-0003-4472-2067
Veronika HorkováLaboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0002-3679-2236
Yi-Fang WangMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Sara Ruiz GilCNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Gustavo Rodriguez-EstebanCNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Irene Robles-RebolloMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Ludovica BrunoMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Radina GeorgievaMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Bhavik PatelMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
James ElliottMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Marian H DoreMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.
Danielle DaupharsDepartment of Immunology, Duke University Medical Center, Durham, NC, USA.
Michael S KrangelDepartment of Immunology, Duke University Medical Center, Durham, NC, USA.
Boris LenhardMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.ORCID 0000-0002-1114-1509
Holger HeynCNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0002-3276-1889
Amanda G FisherMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK.ORCID 0000-0003-3010-3644
Ondřej ŠtěpánekLaboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.ORCID 0000-0002-2735-3311
Matthias MerkenschlagerMRC London Institute of Medical Sciences, Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London, UK. matthias.merkenschlager@lms.mrc.ac.uk.ORCID 0000-0003-2889-3288
MRC London Institute of Medical Sciences · GBCentre for Genomic Regulation · ESCzech Academy of Sciences, Institute of Molecular Genetics · CZDuke Medical Center · USKing's College London · GBShanghai Jiao Tong University · CN

Funding

Basic Immunology Training ProgramT32AI052077 · NIAID · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2002 to 2024
$4.2M
Chromatin regulation of TCR locus V(D)J recombinationR35GM136284 · NIGMS · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2020 to 2024
$2.4M
Medical Research Council MC_U120027516Medical Research Council MC_UP_1102/1Medical Research Council MC_UP_1605/12NIAID NIH HHS T32 AI052077NIGMS NIH HHS R35 GM136284Wellcome TrustWellcome Trust 099276/Z/12/Z
6 · The paper itself

Abstract

CD4 and CD8 mark helper and cytotoxic T cell lineages, respectively, and serve as coreceptors for MHC-restricted TCR recognition. How coreceptor expression is matched with TCR specificity is central to understanding CD4/CD8 lineage choice, but visualising coreceptor gene activity in individual selection intermediates has been technically challenging. It therefore remains unclear whether the sequence of coreceptor gene expression in selection intermediates follows a stereotypic pattern, or is responsive to signaling. Here we use single cell RNA sequencing (scRNA-seq) to classify mouse thymocyte selection intermediates by coreceptor gene expression. In the unperturbed thymus, Cd4

Indexed as

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationCell LineageCore Binding Factor Alpha 3 SubunitCytokinesDNA-Binding ProteinsGene Expression RegulationHistocompatibility AntigensLymphocyte ActivationMiceMice, Inbred C57BLPrincipal Component AnalysisReceptors, Antigen, T-CellRNA, MessengerCore Binding Factor Alpha 3 SubunitCytokinesDNA-Binding ProteinsHistocompatibility AntigensReceptors, Antigen, T-CellRNA, MessengerRunx3 protein, mouseTranscription FactorsZbtb7b protein, mouse

Identifiers

PMID33397934
PMCPMC7782583
OpenAlexW3120834912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.